ECKERT+ZIEGLERINH O.N. news, videos and press releases - Page 5
For more news please use our advanced search feature.
ECKERT+ZIEGLERINH O.N. - More news...
ECKERT+ZIEGLERINH O.N. - More news...
- DGAP-Adhoc: Eckert & Ziegler Divests From Tumour Irradiation Business
- DGAP-Adhoc: Eckert & Ziegler 2020: Earnings higher than expected
- DGAP-News: Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China
- DGAP-News: Eckert & Ziegler Wins Order for Hot Cell Construction from Dutch Research Center
- DGAP-Adhoc: Eckert & Ziegler: PENTIXAPHARM Lead Candidate PENTIXAFOR Can Go in Phase III Study, EMA says
- DGAP-News: Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA
- DGAP-News: Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care
- DGAP-News: Nine-Month Figures Eckert & Ziegler: Growth in Radiopharmaceuticals Compensates for Corona Losses
- DGAP-Adhoc: Eckert & Ziegler to Run Tumor Radiation Business Through TCL Healthcare Equipment
- DGAP-News: Eckert & Ziegler Receives Approval for Gallium-68 Generator for Canada
- DGAP-News: Eckert & Ziegler Records Solid Half-Year Results. Growth Trend for Radiopharmaceuticals Remains Intact.
- DGAP-News: Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020
- DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share
- DGAP-News: Q1 Performance Stable despite Oil Price Slump and Corona Expenses. Strong Growth in Radiopharmaceutical Products
- DGAP-News: US health authorities to provide USD 6 million in funding for MYELO radiation protection pill
- DGAP-News: Eckert & Ziegler Enters TecDAX
- DGAP-News: Eckert & Ziegler with Record Profit in FY 2019
- DGAP-Adhoc: Eckert & Ziegler: Executive Board Proposes Dividend and Share Split
- DGAP-News: Eckert & Ziegler receives CE approval for innovative irradiation applicators using 3D printing
- DGAP-News: Eckert & Ziegler Classified in California as Essential Business
- DGAP-News: Eckert & Ziegler Starts Commercial Production of Lutetium-177
- DGAP-Adhoc: Eckert & Ziegler Reorganizes its Production Sites
- DGAP-News: Eckert & Ziegler to Financially Back Clinical Development of Innovative Lymphoma Treatment
- DGAP-News: Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures
- DGAP-News: Eckert & Ziegler Starts Development Cooperation for Prostate Cancer Diagnosis
- DGAP-News: Eckert & Ziegler to Open up US-Production Site for Yttrium-90
- DGAP-News: Eckert & Ziegler: Strong nine-month figures. Annual forecast confirmed. Pooling of medical segments in 2020.
- DGAP-News: Eckert & Ziegler to supply radioisotopes to Alpha Tau
- DGAP-News: Eckert & Ziegler: additional production capacities for Gallium-68-Generators released by supervisory authorities
- DGAP-News: Eckert & Ziegler: Strong Growth in Sales and Income
